Glickman Marc H. 4
4 · Hancock Jaffe Laboratories, Inc. · Filed Jul 30, 2019
Insider Transaction Report
Form 4
Glickman Marc H.
See Remarks
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-07-26−184,500→ 0 totalExercise: $10.00Exp: 2026-10-01→ Common Stock (184,500 underlying) - Award
Stock Option (Right to Buy)
2019-07-26+184,500→ 184,500 totalExercise: $2.00From: 2019-07-26Exp: 2026-10-01→ Common Stock (184,500 underlying) - Award
Stock Option (Right to Buy)
2019-07-26+180,000→ 180,000 totalExercise: $2.00Exp: 2029-07-26→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]The reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 1, 2016, and provides that the options will have vested over a period of 2 years, with 1/5th of the shares subject to the option vested on October 1, 2016, and with the remaining shares vesting in equal monthly installments over the 24 months thereafter.
- [F2]The shares subject to the option shall vest quarterly over a three (3) year period commencing on July 26, 2019.